RNA polymerase inhibitors reveal active-site motions essential for the nucleotide addition cycle.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42378287.
- Also identified by DOI 10.1073/pnas.2609228123.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The nucleotide addition cycle (NAC) of multisubunit DNA-dependent RNA polymerases (RNAPs) involves coordinated conformational changes in conserved active-site structural elements, including the trigger loop (TL). The TL is open (unfolded) in most RNAP structures but can close (fold) in substrate-bound (post- or pretranslocated) states of the RNAP, promoting catalysis. TL closure has been associated with closure of another conserved structural element, the Rim-Helices/F-loop (RH-FL), but the role of the RH-FL in the NAC is unclear. Antibiotic leads CBR9379 and AAP-SO<sub>2</sub> inhibit the <i>Escherichia coli</i> and <i>Mycobacterium tuberculosis</i> RNAPs, respectively, by binding in a pocket formed by the bridge helix and RH-FL. The precise mechanism of action for these inhibitors is yet to be defined. We present cryoelectron microscopy structures showing that both compounds inhibit the RNAP NAC by preventing RH-FL closure, thereby allosterically destabilizing the closed TL. This work reveals a conserved mechanistic principle of RNAP catalysis across all domains of life and provides insight for antibiotic design.
Medical subject headings
- DNA-Directed RNA Polymerases
- Nucleotides
- Enzyme Inhibitors